Hemostemix (HEM) News Today → A letter is coming from the 'Bureau of the Fiscal Service'. (From Stansberry Research) (Ad) Free HEM Stock Alerts C$0.04 0.00 (0.00%) (As of 05/17/2024 05:18 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesInsider TradesStock AnalysisChartHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 2, 2024 | finance.yahoo.comGlobal Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsightMarch 7, 2024 | finanznachrichten.deHemostemix Inc.: Hemostemix Announces Engagement of Oak Hill Asset Management Inc.March 7, 2024 | finance.yahoo.comHemostemix Announces Engagement of Oak Hill Asset Management Inc.February 20, 2024 | theglobeandmail.comHemostemix: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (HEM)February 19, 2024 | theglobeandmail.comHemostemix: Top 10 Undervalued Biotechnology Industry Stocks (HEM)February 6, 2024 | finance.yahoo.comHemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental SciencesJanuary 19, 2024 | morningstar.comHemostemix Inc HMTXFOctober 30, 2023 | finanznachrichten.deHemostemix Inc.: Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart DiseaseOctober 30, 2023 | finance.yahoo.comHemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart DiseaseOctober 20, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc down on Thursday (HEM)August 29, 2023 | finance.yahoo.comHemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant ApplicationsAugust 8, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc up on Friday (HEM)June 28, 2023 | finanznachrichten.deHemostemix Inc.: Hemostemix Closes $403,539 of the Unit Private PlacementJune 28, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc up on Tuesday (HEM)June 28, 2023 | finance.yahoo.comHemostemix Closes $403,539 of the Unit Private PlacementJune 27, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc down on Monday (HEM)June 24, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc flat on Wednesday (HEM)June 22, 2023 | marketwatch.comHemostemix's Private Placement Use of ProceedsJune 17, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc down on Friday (HEM)June 2, 2023 | msn.comHemostemix to raise $1.2M through private placement of unitsMay 3, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc flat on Tuesday (HEM)May 2, 2023 | finance.yahoo.comHemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant CompanyApril 29, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc flat on Friday (HEM)April 21, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc flat on Thursday (HEM)April 20, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc up on Wednesday (HEM)April 19, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc down on Tuesday (HEM)April 18, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc up on Monday (HEM)April 13, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc down on Wednesday (HEM)April 7, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc up on Thursday (HEM)April 3, 2023 | finance.yahoo.comHemostemix' Second Round Interviews with Executive Vice President Business Development CandidatesMarch 29, 2023 | finance.yahoo.comPeripheral Artery Disease Market to Showcase Growth at a Paltry CAGR of 4% During the Study Period (2019-2032) | DelveInsightMarch 21, 2023 | finance.yahoo.comHemostemix Closes $762,400 of The Unit Private PlacementMarch 8, 2023 | finance.yahoo.comHemostemix Unit Offering RepricedJanuary 31, 2023 | yahoo.comThe Force Family Office Engaged by HemostemixJanuary 30, 2023 | finance.yahoo.comHemostemix' "Your Fountain of Youth" Trademark Granted by SwitzerlandJanuary 26, 2023 | benzinga.comHemostemix' "Your Fountain of Youth" Trademark Granted by Japan Patent OfficeJanuary 26, 2023 | marketwatch.comCritical Limb Ischemia Drug Market 2023 : Company Profile Analysis, Industry Segmentation, Opportunity Assessment and Forecast by 2028January 24, 2023 | finance.yahoo.comHemostemix Wins Arbitration DecisionJanuary 23, 2023 | reuters.comHEM.V - | Stock Price & Latest News | ReutersJanuary 23, 2023 | benzinga.comHemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year CostsJanuary 19, 2023 | benzinga.comHemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre FoundationJanuary 17, 2023 | marketwatch.comCritical Limb Ischemia Drug Market 2023 to 2028 SWOT Analysis & Consumer Demographics Trends with Prominent PlayersDecember 8, 2022 | finance.yahoo.comHemostemix Issued 'Your Fountain of Youth' Trademark by CyprusNovember 30, 2022 | ca.finance.yahoo.comHemostemix Thanks Neim Malo, Beefstro's Founder, for His ACP-01 Testimonial InterviewNovember 18, 2022 | ca.finance.yahoo.comHemostemix Thanks Six-Time Grammy Award Winner, Howie Lindeman, for his ACP-01 Testimonial InterviewNovember 18, 2022 | ca.finance.yahoo.comHemostemix Thanks Six-Time Grammy Award Winner, Howie Lindeman, for his ACP-01 Testimonial InterviewNovember 15, 2022 | finanznachrichten.deHemostemix Inc.: Hemostemix Announces Advancements in Its Automation of ProductionNovember 15, 2022 | finance.yahoo.comHemostemix Announces Advancements in Its Automation of ProductionOctober 26, 2022 | finance.yahoo.comHemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical TrialsOctober 25, 2022 | yahoo.comHemostemix Announces Presentation to the Emerging Growth Conference Get Hemostemix News Delivered to You Automatically Sign up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter. Email Address 4 Cryptos BETTER than Bitcoin (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 HEM Media Mentions By Week HEM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HEM News Sentiment▼0.000.50▲Average Medical News Sentiment HEM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HEM Articles This Week▼00▲HEM Articles Average Week Get Hemostemix News Delivered to You Automatically Sign up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Quest PharmaTech News Innovotech News Solarvest BioEnergy News Aeterna Zentaris News Aequus Pharmaceuticals News Entourage Health News CardioComm Solutions News Titan Medical News Delta 9 Cannabis News Voyageur Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:HEM) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
